Stay Ahead of Compliance with Monthly Citation Updates


In your State Survey window and need a snapshot of your risks?

Survey Preparedness Report

One Time Fee
$79
  • Last 12 months of citation data in one tailored report
  • Pinpoint the tags driving penalties in facilities like yours
  • Jump to regulations and pathways used by surveyors
  • Access to your report within 2 hours of purchase
  • Easily share it with your team - no registration needed
Get Your Report Now →

Monthly citation updates straight to your inbox for ongoing preparation?

Monthly Citation Reports

$18.90 per month
  • Latest citation updates delivered monthly to your email
  • Citations organized by compliance areas
  • Shared automatically with your team, by area
  • Customizable for your state(s) of interest
  • Direct links to CMS documentation relevant parts
Learn more →

Save Hours of Work with AI-Powered Plan of Correction Writer


One-Time Fee

$49 per Plan of Correction
Volume discounts available – save up to 20%
  • Quickly search for approved POC from other facilities
  • Instant access
  • Intuitive interface
  • No recurring fees
  • Save hours of work
F0760
D

Significant Medication Error Due to Improper Insulin Administration

Taylor, Pennsylvania Survey Completed on 04-25-2025

Penalty

No penalty information released
tooltip icon
The penalty, as released by CMS, applies to the entire inspection this citation is part of, covering all citations and f-tags issued, not just this specific f-tag. For the complete original report, please refer to the 'Details' section.

Summary

A registered nurse failed to properly verify and administer insulin to a resident with Type 2 Diabetes Mellitus and parkinsonism. The nurse administered 10 units of Novolog insulin using a pen that had expired beyond the manufacturer-recommended 28-day usage period. The nurse did not check the expiration date on the insulin pen prior to administration, as required by facility policy. Additionally, the nurse documented that Basaglar insulin was given, but in reality, Novolog was administered instead. Review of the resident's physician orders showed that Basaglar was to be administered once daily, and Novolog was to be given only per a sliding scale for elevated blood glucose levels. At the time of administration, the resident's blood glucose did not meet the threshold for Novolog per the sliding scale, and Basaglar was not available on the medication cart as required. Documentation revealed that Novolog had been administered multiple times without corresponding elevated blood sugar readings, and the nurse admitted to not following the physician's orders or verifying the medication label. The Director of Nursing confirmed these findings, resulting in a significant medication error.

An unhandled error has occurred. Reload 🗙